- Human（2）
No data
- -（1）
- His Tag & Flag Tag（1）
No data
- HEK293（2）
No data
- Unconjugated（2）
No data
- RUO（2）
No data
- No（2）
No data
- 20ug/$805.00
- 100ug/$2985.00
- 500ug/$7480.00
No data
- 20ug/$620.00
- 100ug/$1235.00
- 500ug/$4305.00
No data
| Molecule | Cat. No. | Product Name | Art | Host | Structure | Purity | Activity | Size&Price | Add to Cart |
|---|---|---|---|---|---|---|---|---|---|
| ADORA2A | Human ADORA2A Protein, Flag,His Tag (Detergent) |  Human | HEK293 | SDS-PAGE | $805.00 20ug |   | |||
| ADORA2A | Human ADORA2A Full Length Protein (VLP) | Human | HEK293 | HPLC | $620.00 20ug | |
| Englischer Name | Forschungscode | Forschungsphase | Firma | Indikationen | Klinische Studie |
|---|---|---|---|---|---|
| Naproxen/Caffeine | BAY-2880376 | Phase 3 Clinical | Bayer AG | Pain, Postoperative | Details |
| Imaradenant | AZD-4635; HTL-1071 | Phase 2 Clinical | Nxera Pharma UK Ltd | Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Solid tumours | Details |
| Ciforadenant | CPI-444; V-81444 | Phase 2 Clinical | Vernalis (R&D) Ltd | Attention Deficit Disorder with Hyperactivity; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Multiple Myeloma; Neoplasms; Parkinson Disease | Details |
| Caffeinol | Phase 2 Clinical | Cardium Therapeutics | Alcoholic Intoxication; Alcoholism; Carcinoma, Non-Small-Cell Lung; Disruptive, Impulse Control, and Conduct Disorders; Ischemic Stroke | Details | |
| Etrumadenant | AB-928; GS-0928 | Phase 2 Clinical | Arcus Biosciences Inc | Breast Neoplasms; Carcinoma, Merkel Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Pancreatic Ductal; Carcinoma, Renal Cell; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Colorectal Neoplasms; Endometrial Neoplasms; Esophageal Neoplasms; Head and Neck Neoplasms; Hormone-Resistant Prostate Neoplasms; Hypopharyngeal Neoplasms; Laryngeal Neoplasms; Lung Neoplasms; Melanoma; Mouth Neoplasms; Neoplasm Metastasis; Oral Squamous Cell Carcinoma; Oropharyngeal Neoplasms; Oropharyngeal Squamous Cell Carcinoma (OPSCC); Ovarian Neoplasms; Pharyngeal Neoplasms; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Rectal Neoplasms; Squamous Cell Carcinoma of Head and Neck; Stomach Neoplasms; Triple Negative Breast Neoplasms; Urinary Bladder Neoplasms | Details |
| PORT-8 | PORT-8; TT-53 | Phase 2 Clinical | Tarus Therapeutics Inc | Solid tumours | Details |
| ND10(Theialife Inc) | ND-10; ND10 | Phase 2 Clinical | Theialife Inc | Cataract; Dry Eye Syndromes; Myopia | Details |
| PORT-6 | PORT-6; TT-10 | Phase 2 Clinical | Impetis Biosciences Ltd | Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Colorectal Neoplasms; Endometrial Neoplasms; Neoplasms; Ovarian Neoplasms; Prostatic Neoplasms, Castration-Resistant; Squamous Cell Carcinoma of Head and Neck | Details |
| MK-1088 | MK-1088 | Phase 2 Clinical | Merck Sharp & Dohme LLC | Solid tumours | Details |
| VG081821AC | VG081821AC; VG-081821AC | Phase 2 Clinical | Zhejiang Vimgreen Pharmaceuticals Ltd | Metabolic Dysfunction-Associated Steatotic Liver Disease; Parkinson Disease | Details |
| ILB-2109 | WTS-001; ILB-2109 | Phase 2 Clinical | Hangzhou Wutong Tree Pharmaceutical Co Ltd | Carcinoma, Non-Small-Cell Lung; Endometrial Neoplasms; Head and Neck Neoplasms; Hodgkin Disease; Melanoma; Nasopharyngeal Carcinoma; Neoplasms; Ovarian Neoplasms; Sarcoma; Solid tumours; Triple Negative Breast Neoplasms; Uterine Cervical Neoplasms | Details |
| PBF-999 | PBF-999 | Phase 1 Clinical | Palobiofarma Sl | Huntington Disease; Neoplasms | Details |
| [18F]MNI-444 | [18F]MNI-444 | Phase 1 Clinical | Invicro Llc | Diagnostic agents | Details |
| SHR-5126 | SHR-5126 | Phase 1 Clinical | Jiangsu Hengrui Medicine Co Ltd | Neoplasms | Details |
| Taminadenant | NIR-178; PBF-509 | Phase 1 Clinical | Palobiofarma Sl | Carcinoma; Carcinoma, Non-Small-Cell Lung; Carcinoma, Pancreatic Ductal; Carcinoma, Renal Cell; Colorectal Neoplasms; Head and Neck Neoplasms; Lymphoma, Large B-Cell, Diffuse; Melanoma; Ovarian Neoplasms; Pancreatic Neoplasms; Parkinson Disease; Prostatic Neoplasms, Castration-Resistant; Solid tumours; Triple Negative Breast Neoplasms | Details |
| ST-4206 | ST-4206 | Phase 1 Clinical | Alfasigma Spa | Parkinson Disease | Details |
| CKD-512 | CKD-512 | Phase 1 Clinical | Chong Kun Dang Pharmaceutical Corp | Neoplasms; Solid tumours | Details |
| JNJ-86974680 | JNJ-86974680 | Phase 1 Clinical | Johnson & Johnson Enterprise Innovation Inc | Carcinoma, Non-Small-Cell Lung; Prostatic Neoplasms | Details |
| YZJ-5053 | YZJ5053; YZJ-5053 | Phase 1 Clinical | Shanghai Haiyan Pharmaceutical Technology Co Ltd | Neoplasm Metastasis; Solid tumours | Details |
| CT-1500 | CT-1500 | Phase 1 Clinical | Circadian Technologies Ltd | Details | |
| DZD-2269 | DZD-2269 | Phase 1 Clinical | Dizal Pharmaceutical Co Ltd | Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant | Details |
| INCB-106385 | INCB-106385 | Phase 1 Clinical | Incyte Corp | Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Pancreatic Ductal; Colorectal Neoplasms; Gastrointestinal Neoplasms; Ovarian Neoplasms; Prostatic Neoplasms, Castration-Resistant; Solid tumours; Squamous Cell Carcinoma of Head and Neck; Triple Negative Breast Neoplasms; Urinary Bladder Neoplasms | Details |
| CS-3005 | CS-3005 | Phase 1 Clinical | Cstone Pharmaceuticals (Suzhou) Co Ltd | Solid tumours | Details |
| Englischer Name | Forschungscode | Forschungsphase | Firma | Frühestes Markenname | Frühestes Genehmigungsland | Früheste Indikation | Früheste Genehmigungsgesellschaft | Früheste Genehmigungsdatum | Indikationen | Klinische Studie |
|---|---|---|---|---|---|---|---|---|---|---|
| Regadenoson Hydrate | CVT-3146 | Approved | Astellas Pharma Inc | Rapiscan, 海诺生, Lexiscan | United States | Contrast agents | Astellas Pharma Inc | 2008-04-10 | Anemia, Sickle Cell; Astrocytoma; Cardiovascular contrast agents; Cardiovascular Diseases; Contrast agents; Coronary Artery Disease; Coronavirus Disease 2019 (COVID-19); Diagnostic agents; Glioblastoma; Glioma; Heart Diseases; Myocardial Ischemia; Oligodendroglioma; Pneumonia; Rejection of lung transplantation; Retinal Artery Occlusion | Details |
| Caffeine/Ergotamine Tartrate | Approved | Novartis Pharma Ag | Cafergot | Japan | Vascular Headaches; Migraine Disorders; Tension-Type Headache | Nichi-Iko Pharmaceutical Co Ltd | 1948-11-26 | Migraine Disorders; Tension-Type Headache; Vascular Headaches | Details | |
| Oxtriphylline | Approved | Theocolin | Canada | null | Asthma | Details | ||||
| Caffeine/Metamizole Sodium/Dihydroergotamine Mesylate | Approved | Cefaliv | Migraine Disorders | Details | ||||||
| Adenine | Approved | Leucon | Japan | Leukopenia | Ohara Pharmaceutical Co Ltd | Leukemia; Leukopenia | Details | |||
| Acetaminophen/Butalbital/Caffeine/Codeine Phosphate | Approved | Actavis Laboratories Ut Inc | United States | Headache; Headache Disorders | Actavis Laboratories Ut Inc | 1992-07-30 | Headache; Headache Disorders | Details | ||
| Istradefylline | KW-6002 | Approved | Kyowa Hakko Kirin Co Ltd | Nourianz, Nouriast | Japan | Parkinson Disease | Kyowa Hakko Kirin Co Ltd | 2013-03-25 | Amyotrophic Lateral Sclerosis; Cognition Disorders; Hepatic Insufficiency; Movement Disorders; Parkinson Disease; Restless Legs Syndrome; Sleep Wake Disorders; Substance-Related Disorders | Details |
| Sodium Citrate/Citric Acid/Dextrose/Monosodium phosphate/Adenine/Mannitol/Sodium Chloride | Approved | Details | ||||||||
| Sodium Citrate/Citric Acid/Dextrose | Approved | Details | ||||||||
| Sodium Citrate/Citric Acid/Dextrose/Monosodium phosphate/Adenine | Approved | Details | ||||||||
| Aspirin/Acetaminophen/Caffeine/Thiamine | Approved | Fever; Pain | Details | |||||||
| Propranolol hydrochloride/Caffeine/Phenytoin Sodium | Approved | Mainland China | Hebei Tiancheng Pharmaceutical Co Ltd | Details | ||||||
| Salicylamide/Acetaminophen/Caffeine | Approved | Arthralgia; Fever; Headache; Neuralgia; Rheumatic Diseases | Details | |||||||
| Compound Paracetamol Caffeine and Pseudoephedrine Hydrochloride | Approved | Common Cold | Details | |||||||
| Acetaminophen/Methylephedrine Hydrochloride/Dextromethorphan Hydrobromide/Chlorphenamine Maleate/Caffeine/Sulfogaiacol | Approved | Mainland China | Common Cold | Zhejiang Apeloa Kangyu Pharmaceutical Co Ltd | Common Cold | Details | ||||
| Dextromethorphan Hydrobromide/Chlorphenamine Maleate/Sodium Citrate/Ammonium Chloride/Caffeine | Approved | 尔可芬 | Cough | Details | ||||||
| Acetaminophen/Caffeine/Codeine Phosphate/Diphenhydramine Hydrochloride | Approved | 斯力帮 | Headache | Details | ||||||
| Ferric Ammonium Citrate/Vitamin B1/Sodium glycerophosphate/Caffeine | Approved | Ischemia | Details | |||||||
| Norethidranum Dipropionas/Caffeine/Vitamin B6 | Approved | Mainland China | Contraception | Huazhong Pharmaceutical Co Ltd | 1981-01-01 | Contraception | Details | |||
| Acetaminophen/Propyphenazone/Caffeine | Approved | 散利痛, 散列通 | Common Cold | Details | ||||||
| Quinine Hydrochloride Hydrate/Caffeine | Approved | Malaria | Details | |||||||
| Dihydroergocryptine/Caffeine | Approved | 洛斯宝, VASOBRAL | Diabetes Mellitus; Diabetic Retinopathy | Details | ||||||
| Aminophenazone/Phenacetin/Caffeine | Approved | Fever; Pain | Details | |||||||
| Aminophenazone/Caffeine/Calcium Glycerophosphate | Approved | Dysmenorrhea; Headache; Neuralgia | Details | |||||||
| Acetaminophen/Caffeine/Chlorphenamine Maleate | Approved | Common Cold | Details | |||||||
| Aminophenazone/Caffeine/Chlorphenamine Maleate | Approved | Common Cold; Headache; Neuralgia | Details | |||||||
| Aspirin/Caffeine/Codeine Phosphate | Approved | 柯克 | Pain | Details | ||||||
| Acetaminophen/Pseudoephedrine Hydrochloride/Caffeine | Approved | Common Cold | Details | |||||||
| Aspirin/Acetaminophen/Caffeine/Chlorphenamine Maleate | Approved | Common Cold | Details | |||||||
| Aspirin/Caffeine/Chlorphenamine Maleate/Tartaric Acid | Approved | Common Cold | Details | |||||||
| Acetaminophen/Caffeine/Pseudoephedrine Hydrochloride/Chlorphenamine Maleate | Approved | Common Cold | Details | |||||||
| Aminophenazone/Phenacetin/Caffeine/Phenobarbital | Approved | Migraine Disorders | Details | |||||||
| Acetaminophen/Chlorphenamine Maleate/Caffeine/Guaifenesin | Approved | Common Cold | Details | |||||||
| Acetaminophen/Amantadine Hydrochloride/Caffeine/Artificial Bezoar | Approved | Common Cold | Details | |||||||
| Acetaminophen/Salicylamide/Pseudoephedrine Hydrochloride/Caffeine/Triprolidine Hydrochloride Hydrate | Approved | 联邦菲迪乐 | Common Cold | Details | ||||||
| Sodium Benzoate/Caffeine | Approved | Central Nervous System Diseases | Details | |||||||
| Aminophenazone/Caffeine | Approved | Fever | Details | |||||||
| Antipyrine/Caffeine | Approved | Common Cold | Details | |||||||
| Aspirin/Caffeine | Approved | Common Cold | Details | |||||||
| Antipyrine/Caffeine/Citric Acid | Approved | 米格来宁 | Mainland China | Sedation | Mudanjiang Lingtai Medicdment Co Ltd, Xi'An Disai Biological Pharmaceutical Co Ltd, Heilongjiang Hasing Pharmaceutical Group Co Ltd, Huadong Medicine (Xi'An) Bodyguard Pharmaceutical Co Ltd | 1982-01-01 | Sedation | Details | ||
| Aminophenazone/Acetaminophen/Caffeine/Chlorphenamine Maleate | Approved | 克感敏, 扑感敏, 朴感敏 | Common Cold | Details | ||||||
| Acetaminophen/Caffeine/Ephedrine Hydrochloride/Diphenhydramine Hydrochloride | Approved | Influenza, Human | Details | |||||||
| Acetaminophen/Caffeine/Chlorphenamine Maleate/Artificial Bezoar | Approved | Common Cold | Details | |||||||
| Aspirin/Phenacetin/Caffeine | Approved | Arthralgia; Dysmenorrhea; Fever; Headache; Neuralgia; Toothache | Details | |||||||
| Aspirin/Caffeine/Acetaminophen | Approved | United States | Migraine Disorders | Haleon PLC | Anesthesia; Migraine Disorders | Details | ||||
| Acetaminophen/Butalbital/Caffeine | Approved | Headache | Details | |||||||
| Acetaminophen/Caffeine | Approved | Zentiva As | Mainland China | Pain | Sino--American Shanghai Squibb Pharmaceutical Ltd | Pain | Details | |||
| Sodium glycerophosphate/Caffeine/Vitamin B/Phosphoric Acid/Niacin | Approved | Details | ||||||||
| Acetaminophen/Caffeine/Phenylephrine Hydrochloride/Chlorphenamine Maleate/Vitamin B | Approved | Details | ||||||||
| Acetaminophen/Chlorphenamine Maleate/Methylephedrine Hydrochloride/Sulfogaiacol/Caffeine | Approved | Mainland China | Common Cold | Hainan Sanfengyou Pharmaceutical Co Ltd | 2006-05-16 | Common Cold | Details | |||
| Brompheniramine Maleate/Bromhexine Hydrochloride/Caffeine/Acetaminophen/Phenylephrine Hydrochloride | Approved | Common Cold | Details | |||||||
| Acetaminophen/Amantadine Hydrochloride/Caffeine/Chlorphenamine Maleate/Artificial Bezoar | Approved | 复方氨酚烷胺 | Mainland China | Common Cold | null | 1984-01-01 | Common Cold | Details | ||
| Caffeine | Approved | Apnea; Cocaine-Related Disorders; Cognitive Dysfunction; Consciousness; Delirium; Diabetes Complications; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Disorders of Excessive Somnolence; Fatigue; Fetal Membranes, Premature Rupture; Intermittent Claudication; Memory Disorders; Mental Fatigue; Parkinson Disease; Postoperative Cognitive Complications; Sexual Dysfunction, Physiological; Sleepiness; Spinal Cord Injuries | Details |
